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PREFACE 
 
This is the final report of a systematic review conducted as part of the Australian 
Primary Health Care Research Institute (APHCRI) Stream Four funding. The aim of 
Stream Four was to systematically identify, review, and synthesise knowledge about 
primary health care organisation, funding, delivery and performance and then consider 
how this knowledge might be applied in the Australian context. This particular review 
focussed on the management of chronic diseases in the primary care setting. 
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BACKGROUND AND RATIONALE 
The World Health Organisation (WHO) defines chronic diseases as having one or more 
of the following characteristics: they are permanent, leave residual disability, are 
caused by non-reversible pathological alteration, require special training of the patient 
for rehabilitation, or may be expected to require a long period of supervision, 
observation, or care. The Australian Institute of Health and Welfare (AIHW) listed the 
12 chronic diseases that had the greatest impact on the Australian health care system. 
They were coronary heart disease, stroke, lung cancer, colorectal cancer, depression, 
diabetes, asthma, chronic obstructive pulmonary disease, chronic kidney disease, oral 
diseases, arthritis and osteoporosis (1).  Increasingly people with chronic disease are 
being managed in primary care by general practitioners and other primary health care 
professionals often in collaborative arrangements with specialised services.  
 
The Bettering the Evaluation and Care of Health (BEACH) report (2) identified those 
chronic diseases most commonly managed in primary care. They were hypertension, 
coronary heart disease, depression, diabetes, lipid disorders, asthma, chronic 
obstructive pulmonary disease, arthritis (including osteoarthritis and rheumatoid 
arthritis) and osteoporosis. Our intention in this review was to focus on those chronic 
diseases most commonly managed in primary care. Whilst lung cancer and colorectal 
cancer are important they are not frequently managed in primary care and therefore 
contribute less to the total burden of chronic disease seen in that context. 
 
Weingarten’s definition of chronic disease management is “an intervention designed to 
manage or prevent a chronic condition using a systematic approach to care and 
potentially employing multiple treatment modalities” (3). The WHO definition of chronic 
disease and Weingarten's definition of chronic disease management (CDM) have been 
used in developing our research questions. The review has been informed by the 
Chronic Care Model (CCM) proposed by Wagner and colleagues (4) which includes the 
six elements: health care organisation (HCO), delivery system design (DSD), decision 
support (DS), clinical information system (CIS), self management support (SMS) and 
community resources (CR). 
OBJECTIVES 
The aim of this review was to answer to following research questions: 
1. What is meant by chronic disease management in the primary health care in 
Australia and in comparable countries such as USA, Canada, UK, Netherlands, 
New Zealand and Scandinavia? 
2. How and in what context were the models of chronic disease management 
developed? Why were they developed? 
3. What are the roles of those involved in the models identified? 
4. What are they key outcomes and impacts of the models?  How have they been 
measured? 
5. How effective, efficient and innovative are the models and approaches 
identified? 
6. What are the characteristics of successful (effective, efficient and / or 
innovative) models and approaches in terms of organisation, service delivery 
and funding?  How applicable are these to the Australian context and health 
care system? 
7. What are the facilitators and barriers to effective interventions for chronic 
disease in primary health care? 
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CHRONIC DISEASE MANAGEMENT MODELS 
In Australia and comparable countries there has been a shift in health care from a 
reactive system with a focus on acute care to one that is proactive, which supports the 
management of chronic disease. There has been a range of policy and system wide 
changes to address the management of chronic disease. The aim of this section is to 
describe the development of models for the management of chronic disease, the 
context and roles of those involved. This will form the framework for the later review 
of evidence to support the components of the models.  In particular the following 
questions will be addressed: 
 
1. What is meant by chronic disease management in the primary health care in 
Australia and in comparable countries such as USA, Canada, UK, Netherlands, 
New Zealand and Scandinavia? 
2. How and in what context were the models of chronic disease management 
developed? Why were they developed? 
3. What are the roles of those involved in the models identified? 
4. What are they key outcomes and impacts of the models?  How have they been 
measured? 
INNOVATIVE CARE FOR CHRONIC CONDITIONS (ICCC) 
In response to the global increase in the prevalence of a range of chronic diseases the 
World Health Organisation (WHO) recently published a report: Innovative care for 
chronic conditions: building blocks for action (ICCC) (5). The purpose of the ICCC 
report was to describe a comprehensive global framework for the prevention and 
management of chronic disease, which could be applied to both developed and 
developing countries. The ICCC report stated that healthcare systems around the world 
have developed to deal with acute episodic care, which is not appropriate for the 
management of chronic conditions in the long term. 
 
The WHO identified eight elements essential for the successful management of chronic 
diseases in any healthcare system:  (1) Support a paradigm shift from acute episodic 
care to a system of care that is more suitable for the needs of those with chronic 
conditions;  (2) Manage the political environment to ensure commitment across all 
levels with information sharing;  (3) Build integrated healthcare to ensure that 
information is shared across services, providers and time;  (4) Align sectoral policies 
not only with health but also comprehensively across other areas such as education, 
workforce etc; (5) Effective use of health care personnel in order to maximise the roles 
of all those involved in care of patients and recognise the importance of their roles in 
the management of chronic disease;  (6) Centre care on patient and their family with a 
shift from the patient as a passive recipient of care to a model where the patient takes 
some responsibility for their care.  This is important when lifestyle factors play an 
important role in chronic disease particularly prevention; (7) Support patients in their 
communities with programs that span health care organisations and the wider 
community; (8) Emphasize prevention.  The elements combine to form a triad of care 
between the health care organisation, the patient and their family and the community. 
 
The organisation of health care systems is discussed in terms of macro, meso and 
micro levels and how they contribute to the management of chronic disease.  At the 
macro level governments need policy for preventing and managing chronic disease that 
include both high and low technology approaches with the avoidance of fragmented 
financing and misaligned incentive schemes without regulation or monitoring of 
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standards. At the meso level there should be systems to manage care over time as 
opposed to acute episodic care. This will involve education of health care professionals, 
evidence-based guidelines, prevention strategies, information systems and linking with 
community resources. Finally at the micro level the development of skills for individuals 
to prevent and manage their own health. 
In developing the ICCC the WHO drew from the Chronic Care Model (CCM) developed 
by Wagner and colleagues (4) and expanded this model for use particularly in 
developing countries. 
Chronic Care Model 
The Chronic Care Model (CCM) was developed in the USA after an extensive review of 
the literature and is the most widely known model of care for people with chronic 
conditions (4).  The model describes the elements essential for improvements in the 
care of people with chronic conditions with a focus on primary care. The overall aim of 
the CCM is to develop well-informed patients and a healthcare system that is prepared 
for them. The six elements of the CCM are: 
• Delivery System Design (DSD) The structure of the medical practice to create 
teams with a clear division of labour and separating the acute from the planned 
care.  Planned visits and follow up are important features 
• Self Management Support (SMS) Collaboratively helping patients and their 
families to acquire the skills and confidence to manage their condition. Provide self 
management tools, referrals to community resources, routinely assessing progress 
• Decision Support (DS) Integration of evidence based clinical guidelines into 
practice and reminder systems. Guidelines reinforced by clinical “champions” 
providing education to other health professionals 
• Clinical Information Systems (CIS) Three important roles of computer 
information systems: Reminder system to improve compliance with guidelines, 
feedback on performance measures and registries for planning the care for CD 
• Community Resources (CR) Linkages with hospitals providing patient education 
classes or home care agencies to provide case managers.  Linkages with 
community based resources – exercise programs, self help groups, and senior 
centres 
• Health Care Organisation (HCO) The structure, goals and values of the 
provider organisation. Its relationship with purchaser, insurers and other providers 
underpins the model. (4, 6) 
 
The six elements of the CCM operate within the context of the triangle of the 
community, the health care system and the provider organisation (6) (Figure 1). The 
model allows for division of labour and a switch from acute to long term care. 
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Figure 1. The 
elements of the 
Chronic Care 
Model 
 
Figure from Wagner 
EH. Chronic Disease 
Management: What 
will it take to 
improve care for 
chronic illness.  
Effective Clinical 
Practice 1998;1:2-4.  
Reproduced with the 
permission from the 
American College of 
Physicians 
 
 
 
There have been some attempts to assess the impact of the CCM on the outcomes for 
chronic disease and to try to determine the extent to which the elements of the CCM 
have contributed to care (7, 8). The results suggested that the inclusion of one or 
more element of the CCM resulted in improved patient or process outcomes for a 
variety of chronic diseases.  The chronic care model has not been tested in its entirety 
but elements of the model have been incorporated into policy and programs for the 
management of chronic disease in several countries and these will be detailed below. 
CONTEXT, ROLES AND IMPACTS 
The Chronic Care Model has informed policy for the care of people with chronic disease 
in many countries. The model has been adapted for use in different healthcare systems 
either in its entirety or some of the elements. The aim of the following section is to 
provide some examples of how adaptations of the CCM have been evaluated or 
incorporated into policy in countries comparable to Australia. This will provide insights 
to answer the following questions: 
- How and in what context were the models of chronic disease management 
developed? Why were they developed? 
- What are the roles of those involved in the models identified? 
- What are they key outcomes and impacts of the models?  How have they been 
measured? 
USA 
The CCM was developed within the context of the managed care organisations (MCOs) 
in the USA in an attempt to improve the management of chronic disease and to reduce 
costs to the organisation. The USA has no national system of health care; instead there 
are a series of healthcare providers operating in a market-based system. The US health 
care system is funded on three levels: 
• Government (Federal and State) funds, Medicare which covers much of the 
healthcare for those aged over 65, and Medicaid, which covers healthcare for 
those on low incomes 
• Employers through corporate membership of health insurance 
• Private individuals 
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Access to healthcare in the USA is inequitable and approximately 18% of the 
population have no health insurance (9), many of these will be on low incomes with a 
higher prevalence of chronic disease. The structure of the US health care system 
means that there has been a focus on acute episodic care and the CCM was developed 
to address some of these issues and focus on the long-term planned care, which is 
necessary for the management of chronic disease. In addition, the USA has a poorly 
developed primary health care system (10). 
 
Bodenheimer presented the results of several case studies of organisations that have 
implemented aspects of the CCM in the USA (6). The cases range from a network of 
private medical practices to a large community health centre providing care to the 
Hispanic population, many of who lived below the poverty line. The cases also 
highlighted the differences in the roles of those involved, with physicians in the private 
network and multidisciplinary teams in the community programs. Diabetes care 
improved for the patients of the private practice network when the physicians were 
provided with treatment guidelines, academic detailing and performance feedback. 
There were financial incentives for physicians in place to promote the process and 
plans to extend this to include other chronic diseases and programs that incorporated 
health professionals, other than physicians, to deliver the patient education sessions. 
The community program with Hispanic Americans addressed several aspects of the 
CCM; delivery system design, primary care teams, disease registers, physician 
reminders, decision support, group education sessions and self management including 
goal setting. The program was effective and the mean HbA1c level decreased from 
10.5% to 8.6% in fewer than 18 months (6). 
 
A medical group in Minneapolis underwent a reorganisation of its medical services 
using the CCM as its template.  This provided an opportunity to evaluate the quality of 
care before and after the implementation using the Assessing Chronic Illness Care 
(ACIC) survey (11). In terms of quality improvement, most of the improvements 
demonstrated were associated with decision support, clinical information systems and 
community resources over the two-year period. A qualitative study was undertaken to 
identify what CCM elements were addressed, the strategies used in addition to 
facilitators and barriers encountered (12). Many of the challenges were associated with 
delivery system design. The development of the team varied and often the physician’s 
role remained unchanged. Often the team or process did not engage the physicians so 
the team was built around the physician. The success of the team was more 
dependent on personalities than on the planned roles. The authors concluded that the 
CCM was useful as a conceptual framework but that to be effective in practice there 
needed to be more specific advice or examples to enable health professionals to 
determine precisely what changes to make in the organisation and delivery of care. 
 
In the USA, there have been examples of discrete healthcare providers undergoing 
system wide changes that have provided some evidence for the effectiveness of the 
CCM in terms of the healthcare organisation (HCO). The Department of Veterans 
Affairs (VA) health care system underwent system-wide changes during the mid-1990s. 
The changes to the VA system included integrated medical records, performance data, 
performance contracts and overall management of quality.  An evaluation was 
undertaken comparing the quality of care from 1994 to 2000 with the quality of care in 
a sample from Medicare. Improvements in quality outcomes were evident after two 
years of the changes and were significantly better than those in the Medicare system 
(13). 
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The Indian Health System (IHS) is a federally funded health system that provides 
health care to American Indians and Alaska Natives. This population has a very high 
prevalence of diabetes and diabetic complications and in order to address this, the IHS 
developed a Special Diabetes Program for Indians in 1997, which provided grants for 
diabetes programs aimed at both urban and tribal groups. An audit of diabetes 
outcomes was undertaken for the period 1995 to 2001 (14). There were significant 
improvements in HbA1c, total cholesterol, triglycerides and diastolic blood pressure 
between 1995 and 2001.  Many of the programs that were funded during this period 
were aimed at prevention and management of diabetes in Indians.  The money funded 
a variety of projects, which included healthcare teams, disease registers, case 
management and essential equipment. The results reflected achievements that may be 
possible within certain populations when policy, community and health programs focus 
on one issue.  
 
The King’s Fund recently undertook a qualitative review of the management of chronic 
diseases by MCOs (9) to determine how the CCM worked in these organisations. One 
of the key features of US managed care organisations is that they are decentralised 
and exposed to market forces. There is competition between the organisations to 
recruit insured companies or patients and this was one of the main driving forces 
behind the need for innovative chronic disease management programs. There were 
several organisational features identified by Dixon et al. (9) that may have 
considerable implications for the Australian healthcare system, in particular the way in 
which general practice could in the future work with local health services to provide 
care for people with chronic and complex conditions. These organisational features 
were: 
• Local discretion to set organisational goals and priorities through negotiation 
between corporate and clinical managers 
• Long-term relationships between MCOs and providers (hospitals and physicians) 
• Larger and more organised networks of physicians were more effective than 
looser networks of solo physicians 
• Where MCOs worked exclusively with medical groups then both the provider 
and purchaser had similar incentives to improve care 
• Effective financial incentives for quality to encourage better care (9) 
 
All of the MCOs reviewed based their chronic disease management on the CCM and in 
addition to the six elements of care identified they also stratified their patients 
according to severity. A disease and case management approach was implemented 
according to disease severity and care was delivered by a multidisciplinary team (15).   
 
In spite of the success of MCOs, the USA still lags behind Europe in the management 
of chronic disease with death rates in young people from diabetes five times higher in 
the USA compared to Europe (16).  The structure of the health care system in the USA 
means that those people most likely to have one or more chronic disease are also most 
likely not to have health insurance and access to healthcare. 
United Kingdom 
The UK has looked to the CCM and the US managed care organisations such as 
Evercare and Kaiser Permanente to inform the management of chronic disease in 
primary care. The health system in the UK is different to the USA in that the National 
Health Service is funded by the tax system, access is free and there is a strong focus 
on primary care. The UK initiatives have incorporated most elements of the CCM with a 
specific focus on delivery system design, decision support, clinical information systems 
and self management support.   
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In primary care, patients with chronic disease are often managed using guidelines, 
supported by clinical information systems and often in special “clinics” separate from 
regular urgent care.  Practice nurses have a considerable role in this process. The 
Department of Health identified the management of chronic diseases as a key feature 
of the National Health Service Improvement Plan (17). The program was aimed at 
Primary Care Trusts (PCTs) and Local Authorities (LAs) to focus on health and well 
being in addition to ill health, devolving decision making to a local level and to making 
care more personalised.  
 
One component of the program was the identification of high-risk elderly patients from 
hospital admission data, intensive case management by nurse practitioners and the 
organisation of care around the patient’s need based on the Evercare MCOs program in 
USA.  Community matrons had an important role in the identification and case 
management of patients.  There have been interim analyses of the Evercare pilot 
projects in the UK and so far the results have suggested that high-risk patients could 
be identified this way and that once identified preventive health care was provided and 
there were responses to deterioration in the health of the patient (18). The results of 
the full evaluation will not be available until later in 2006 and therefore it is too early to 
say what impact this program has had on hospital admission rates. 
 
The UK has developed National Service Improvement Frameworks for each of the 
major chronic diseases such as diabetes and cardiovascular disease. These provide a 
framework of standards for PCTs in delivery system design and decision support for 
chronic disease (19). 
 
The Expert Patient Program (EPP) develops the role of the patient in their own care 
and is a chronic disease self management program which comprises of a six-week 
generic training course for adults with a chronic disease run in Primary Care Trust 
(PCT) sites although does not involve GPs (20).  Pilot EPP courses began in May 2002 
and have been deemed a success in terms of the number of PCTs taking part and the 
numbers of courses run (21-23). To date there has not been an evaluation of the 
impact of the EPP on patient outcomes or healthcare utilisation. 
 
In addition to the Evercare pilot programs and the EPP there has been a move to 
reward good quality chronic disease management by GPs through the Quality and 
Outcomes Framework of the general practitioner contracts from 2004. The National 
Institute for Health and Clinical Excellence (NICE) have produced disease specific 
guidelines, which have been used as the national standards of care.  Campbell et al 
(24) reported that in the period 1998 to 2003 there were substantial improvements in 
the quality of care for coronary heart disease, asthma and diabetes but there has not 
been an evaluation, published to date,  of any effect on patient outcomes. The role of 
practice nurses has been important in helping GPs to reach their targets for care. 
Netherlands 
The healthcare system in the Netherlands is complex and characterised by three 
different levels of insurance (25). As a result of the organisation and funding for 
healthcare in the Netherlands there is fragmentation of services.  Transmural care was 
developed in the 1990s to address the gap between hospital and primary care and the 
separate funding systems and targets delivery system design (26). The actual 
components of transmural care programs vary but a recent survey found that most 
hospitals were involved in a program (26).  Nurses play an important role in many of 
the programs in the Netherlands, which involve nurses with specialist training in the 
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management of people with certain conditions, or liaison nurses.  Other approaches 
involved education, guideline development and family support. 
 
A disease management model was adopted by some regions in addition to the 
transmural model.  Disease management for diabetes was developed in the Maastricht 
region (27). This delivery system design model was developed from the experience of 
a shared care for diabetes model where specialist nurses shared the care of diabetes 
patients with hospital specialists and has been extended to include a team of health 
care professionals (GP, practice nurse, specialist nurse, and endocrinologist). The 
balance of care in terms of the care providers was dependent on the severity of the 
patient’s condition. For those patients with more severe disease the balance favoured 
hospital led care. The care was provided according to guidelines and patients were 
encouraged to take some responsibility for their own health care. The evaluation into 
the effectiveness of this model has not yet been completed. 
 
The Dutch College of General Practitioners (NHG) has played an important role in the 
development of practice guidelines, which have played an important role in general 
practice and form the basis for interdisciplinary guidelines between GPs and hospital 
specialists in processes such as transmural care 
(http://nhg.artsennet.nl/content/resources).  
Sweden 
Primary care in Sweden typically involves a multidisciplinary team of health 
professionals and nurses have an important role with advance functions and some 
prescribing authority.  Health care is provided at a local level and the development of 
“Chains of Care” to integrate the care of patients with chronic conditions between 
primary care and other care providers (28). More than half the councils had developed 
“Chains of Care” by 2002 (28) and many of these were concerned with improving care 
for specific conditions such as cancer or diabetes.   The aim of this model has been at 
the delivery system design level to improve the integration of services and there has 
been less focus on the empowerment of the patients at the centre of the care. 
Canada 
Canada lacks a capacity for national PHC reform system wide with most initiatives 
being pilots or implemented at province level. The Canadians have looked to the CCM 
to inform the management of chronic disease. The provinces have the responsibility for 
health service organisation and some attempts are underway to improve coordination 
and continuity of care.  The CCM has been expanded for use in Canada (29) to 
incorporate population health promotion to prevent chronic disease. The community 
resources were expanded to include the five action areas from the Ottawa Charter for 
Health promotion which are to develop personal skills (self management support), re-
orient health services (delivery system design), build healthy public policy, create 
supportive environments and strengthen community action (29).  Many of the 
initiatives from the expanded CCM have been supported by the Primary Health Care 
Transition Fund, which aims to develop primary care reform strategies, improve 
coordination of care and improve health outcomes. In addition to this there are 
programs such as the Vancouver Island Chronic Illness Care Project (http://www.hc-
sc.gc.ca/fnih-spni/services/acces/vancouver_isl-ile_e.html) which is a federal and First 
Nation Health collaborative project to improve care for First Nation people with chronic 
illnesses which addresses many of the components of the CCM such as self 
management, community resources, delivery system design. Diabetes is a major health 
problem within indigenous Canadians and community based projects specific to local 
populations have been developed and funded. 
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New Zealand 
In 2004, the New Zealand Ministry of Health launched Care Plus, a new service for 
people with chronic disease delivered through Primary Health Organisations (PHOs) 
(30). The key feature of the Care Plus program was the identification of people with 
chronic disease who required intensive case management. Once identified and enrolled 
on the program patients were entitled to reduced cost nurse or doctor visits, care 
planning with quarterly checks and self management support to enable them to 
achieve their care plan goals. The PHOs received additional capitation funding of 
around 10% to target 5% of the enrolled population. The Care Plus program was 
introduced to allay the fears of GPs who felt that some of their patients with chronic 
disease might have to pay more for their treatment if their GP was on an Interim 
Formula compared to those whose GP was on an Access Formula. GPs on an Access 
Formula were those who served a population with a higher proportion of Pacific 
Islander, Maori or low socio-economic status and they received additional capitation 
funding for care (31). 
 
The aims of the Care Plus program were to improve the management of chronic 
disease and reduce health inequalities, improve teamwork within PHOs and reduce 
costs for high need patients. Early evaluations suggested that the program had been 
successful in terms of patient and practice satisfaction. As yet there has not been an 
evaluation published to include patient outcomes, health service utilisation or costs.  
Results from the pilot studies suggested that the barriers to implementation were 
apathy among some patients to taking a more active role in their care and staffing 
levels (31, 32). Improving the practice information system and disease registers were 
found to be important to prepare the practice to maximise the funding available for the 
Care Plus program (33). 
 
The Chronic Care Management Model has been developed in the Counties Manukau 
region in South Auckland, New Zealand. The model was developed between the PHO 
and the local health authority and its aim was the “seamless” delivery of healthcare for 
people with chronic diseases (34). Since it was developed the program has been 
extended and in November 2004 there were 4,231 patients with diabetes, CHF, COPD 
or CVD enrolled and of these 23% were Maori and 51% Pacific Islanders (35). Interim 
results suggested that the program had been effective in improving patient outcomes 
and was addressing inequalities in health and patient follow up but it was too early to 
assess the impact on healthcare utilization costs. 
Australia 
The context of the Australian Health Care System is an important consideration in 
reviewing and synthesizing the literature on Chronic Disease Management (CDM) in 
primary care. This context includes the way primary care in Australia is organized and 
financed plus previous and current policy and programs relevant to CDM in primary 
care.  
 
In the Australian health care system primary care services are a complex mixture of 
State and Commonwealth responsibilities with public and private providers. Primary 
care services in Australia include general practice, State funded generalist community 
health services, private allied health services, pharmacies and complimentary therapists 
(36). The largest group providing primary health care services are general 
practitioners. More than 90% of the population see a GP at least once a year and on 
an average people attend 6.5 times per year (37). GPs and private allied health 
professionals, such as, physiotherapists and dieticians, largely work in a small business 
model while most primary health nurses work in the state funded community health 
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services. The divide between State and Commonwealth in terms of responsibilities, 
funding structures, organisation and service delivery is an important feature of the 
Australian health system and has been cited as a barrier to reform (38).  In the area of 
chronic disease the State and Commonwealth divide raises both financial and clinical 
barriers to providing care (39). In response to these barriers a number of policy and 
program responses have been initiated by the Governments at both State and Federal 
levels and many of the initiatives align to elements of the CCM. The initiatives of key 
relevance to chronic disease management in primary care are outlined below. 
 
The coordinated care trials of the 1990s attempted to test better coordination of the 
management of people with chronic and complex needs.  The interventions tested 
varied but typically involved a care coordinator to access services and so align to the 
CCM element of delivery system design. In some trials improved coordination was 
facilitated by funds pooling from different sources within current resource levels. 
Problems in the trials included inadequate periods to test the intervention, difficulties 
with recruitment and diverse patients groups entering the studies. Overall results in the 
first round of trials were that intervention groups did not have better outcomes in the 
quality of life measure used or in rates of hospitalisation, readmission or length of stay. 
Some of the design problems of the first round of trials are being addressed in round 
two. 
 
The Enhanced Primary Care (EPC) package was introduced in 1999 with the aim of 
improving preventive healthcare and coordination of care. These initiatives again align 
to the CCM element of delivery system design and provide a mechanism for funding for 
a change in the role of the general practitioner towards greater involvement in 
structured and co-coordinated care. The package introduced Medicare Benefit Schedule 
(MBS) items for health assessments and care planning. Under the package GPs could 
receive a MBS rebate for initiating or participating in an EPC multidisciplinary care plan. 
The care plans provide a structure for a multidisciplinary approach but general 
practitioners experienced difficulty with using the items related to time, organisation, 
communication, education and resources (40).  New Medicare items for CDM were 
introduced in July 2005 to streamline care planning for patients with chronic conditions 
and to facilitate multidisciplinary care planning (41). These items consist of a GP 
Management Plan and a Team Care Arrangement.  The latter is very similar to the 
previous EPC Care Plan. Specific items for Aboriginal and Torres Strait Islander people 
have been established. An addition to the EPC package is access to allied health 
services. Patients with chronic conditions and complex needs being managed with a 
care plan can receive a rebate for up to five allied health services per year. Patients 
with dental problems that significantly exacerbate their chronic conditions may also 
access rebates for up to three dental services per year. 
 
Incentive programs for the management of diabetes, asthma and mental health were 
introduced as part of the 2001 Federal Budget aimed at supporting better care of these 
conditions in general practice. These initiatives involved both elements of delivery 
system design and decision support. The diabetes and asthma incentives involved a 
payment to the practice through the Practice Incentive Program (PIP) and a Service 
Incentive Payment (SIP) to the individual practitioner on completion of tasks related to 
that condition.  In the case of diabetes it was an annual cycle of care and in the case 
of asthma a series of planned visits. The cycle of tasks was generated from clinical 
practice guidelines on diabetes care while the asthma visits related to a process for 
implementing Australian asthma management guidelines.  General practitioners have 
struggled with the complexity of having a range of different disease-specific incentives 
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introduced at the same time and there have been considerable difficulties with uptake 
and use of the asthma incentive (42). 
 
As well as incentives through the PIP and SIP process the mental health initiative also 
included education and training for GPs; focused psychological strategies; access to 
allied psychological services; and access to psychiatrist support (43). A study 
evaluating the Better Outcomes in Mental Health (BOiMH) programs in two general 
practice divisions in New South Wales showed satisfaction with the program and 
improved patient outcomes (44). However, there were issues with uptake of the 
training by GPs and difficulties with access in some Divisions with the result that some 
programs became oversubscribed. 
 
Although the majority of initiatives to improve chronic disease management in primary 
care have focused on changing the role of general practitioners there have also been 
practice nurse initiatives. Practice nurses have become an integral part of health 
assessments and care plans. Support to assist GPs in rural areas and other areas of 
high workforce need to employ practice nurses was approved in the 2001 Federal 
Budget. Subsequently as part of the Strengthening Medicare announcement the PIP 
practice nurse payment was extended to urban areas of workforce shortage. Practice 
nurses have become increasingly involved in conducting health assessments, 
contributing to GP Management Plans and to Team Care Arrangements. This is a 
change in delivery system design towards an expanded role for nurses in primary care. 
 
Another important innovation has been the National Primary Care Collaboratives 
Program (NPCCP). Introduced in 2004, the aim of the NPCCP was to improve service 
delivery, access and integration of care for patients with complex and chronic 
conditions. The first of the planned three waves focused on care of diabetes and 
secondary prevention of coronary heart disease. The approach relied on local activity in 
practices based on plan/do/study/act (PDSA) cycles. A total of 157 practices from 22 
Divisions were involved in the first wave, which has shown some improvements in 
measures of quality of care for patients with coronary heart disease (45).  
 
There has also been a focus on the CCM element of self management through a 
Commonwealth program focused on chronic disease self management.  The Sharing 
Health Care Initiative 1999-2007 funded twelve demonstration projects of chronic 
disease self management. These programs addressed a range of chronic conditions 
and typically involved education and training for patients and health professionals. Self 
management education programs used have included the Stamford Model (46, 47) and 
the Flinders Model (39). 
 
There have also been initiatives in chronic disease prevention. The Australian 
Government developed the Smoking, Nutrition, Alcohol and Physical Activity (SNAP) 
framework for general practice in response to evidence that lifestyle modification can 
be implemented in general practice but that relatively few encounters involve risk 
factor assessment (48).  Following on from the SNAP initiative the Australian 
Government supported the development of a set of resources to assist GPs to 
incorporate behavioural risk factor management into their practice as part of the 
government’s Focus on Prevention package announced in the 2003-4 Budget. The 
“Lifescripts” risk factor resource kit has been disseminated via Divisions of General 
Practice and includes assessment tools and lifestyle prescription resources on each of 
the four SNAP risk factors.  
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More recently the Council of Australian Governments has announced the Australian 
Better Health Initiative (ABHI), a five-year package aimed at reducing the impact of 
chronic disease. This package includes a Medicare Benefits Schedule item for a 
focussed health check to be available via general practice for people around age 45 
who have one or more identifiable risk factors that may lead to chronic disease. The 
ABHI also includes initiatives to support lifestyle change through individual and group 
lifestyle education to those with modifiable risk factors and a measure to encourage 
patient self management of chronic disease by providing training for health 
professionals, including GPs, in teaching self management skills. The Lifescripts 
resources and these measures that form part of the Better Health Initiative align to 
CCM elements of self management support and delivery system design. 
 
As well as initiatives at national level there have been notable State level programs. For 
example in New South Wales the NSW Chronic Care Program has targeted the care of 
people with chronic and complex problems who are frequent users of the hospital 
system. The types of intervention used have typically been changes in delivery system 
design with care coordinator roles developed such as the role of specialist liaison nurse 
(49). There is some evidence that phase one of the chronic care program resulted in a 
reduction in hospitalisations. Phase two involved the development of clinical service 
frameworks for respiratory disease, heart failure and cancer, use of collaborative 
methodology and the development of service standards for Aboriginal chronic 
conditions (49). Other states have also developed chronic disease programs such as 
the Northern Territory preventable chronic disease strategy (50).  
 
Australia has particular problems with chronic disease among indigenous people. In 
1999-2001, over two-thirds of excess deaths for Aboriginal and Torres Strait Islander 
people were accounted for by diseases of the circulatory system, respiratory system, 
and endocrine, nutritional and metabolic diseases. The self reported rate of diabetes 
was almost four times as high as for other Australians (51). To a substantial extent the 
higher prevalence of chronic disease accounts for the shorter life expectancy of 
Aboriginal and Torres Strait Islander people, which is about 20 years less than non-
Aboriginal Australians.   
 
Primary health care services for Aboriginal and Torres Strait Islander people are 
provided in a number of ways including through Aboriginal Community Controlled 
Health Organisations (ACCHO), outreach services of various kinds and through 
mainstream services such as general practice. Efforts to improve chronic illness care in 
Aboriginal and Torres Strait Island people are made more challenging by geographical 
isolation in rural and remote communities and by workforce and capacity issues in 
primary care services generally. The Coordinated Care Trials included four trials in 
Aboriginal communities with a focus on improved care coordination, use of funds 
pooling and using additional funding calculated on the basis of relative under-use of 
Medicare and Pharmaceutical Benefit Schemes (MBS and PBS) rebates. These trials 
showed improvements in service access and service appropriateness but there were 
also lessons in the need for a comprehensive and sustained approach to building 
capacity in local services and communities (52).  
 
In the Northern Territory the Assessment of Chronic Illness Care scale has been 
adapted and used in Aboriginal community health centres to examine the status of 
systems for care of diabetes. Health centre systems were in the low to mid range of 
development and were comparable to results from the US except for lower scores on 
organisational influence and self management support (53).  
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A number of factors have been identified that are thought to contribute to the success 
of chronic disease programs in Aboriginal people (54). Key factors relevant to initiatives 
in Aboriginal Health in general are: Aboriginal community support and involvement; 
effective local area partnerships and working groups; participation and professionals 
development of Aboriginal Health Workers; adequate resources and coordination 
between existing human, financial and physical resources and initiatives; effective 
planning and evaluation with feedback to the community; and appropriate timeframes 
for the development and implementation of initiatives.  Key factors specific to 
initiatives for early detection and management of chronic conditions among Aboriginal 
people are: accessible early detection and interventions program; local (including 
outreach) multidisciplinary teams or taskforces with clear roles and responsibilities; 
locally agreed evidence-based clinical protocols; and systems for follow up care 
including register and recall systems. 
 
At the macro level a key issue with the approaches to date to improve chronic disease 
management in Australia for both the general population and the indigenous 
population has been the need for greater consistency and linkages between policy and 
program approaches at Commonwealth and State levels. There has been policy work 
to better define and coordinate Australia’s chronic disease policy framework through 
the development of the National Chronic Disease Strategy (NCDS) (55) which seeks to 
provide an overarching policy framework for action on chronic disease. The NCDS does 
not contain implementation strategy; these are expected to be the responsibility of 
individual jurisdictions. The NCDS identifies the following action areas: 
 
1. Prevention across the continuum 
2. Early detection and early treatment 
3. Integration and continuity of prevention and care 
4. Self management 
 
The NCDS has five Supporting Service Improvement Frameworks that cover the 
national health priority areas of asthma; cancer; diabetes; heart; stroke and vascular 
disease; osteoarthritis, rheumatoid arthritis and osteoporosis. The Australian Better 
Health Initiative, discussed above, forms part of the implementation of actions under 
the National Chronic Disease Strategy but coordinated action will be needed from a 
range of stakeholders at national, state and local level if comprehensive 
implementation is to occur. 
 
SUMMARY  
In summary the elements that make up the Chronic Care Model have been adapted for 
use in a variety of developed countries with a range of different health care systems. 
Emphasis has been placed on the elements of the model that address specific issues 
such as disease guidelines or self management within the context of the health care 
system. For example the delivery system design focus of the Transmural Care 
approach in the Netherlands to overcome a fragmented healthcare system (26). In 
other countries the CCM has been used to co-ordinate care in an affordable way for 
patients. 
 
The role of practice nurses and primary care teams have become increasingly 
important to support the role of the GP in managing chronic disease. The role of the 
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patient in their own care is being developed with programs such as the Expert Patient 
Program (EPP) and Stamford and Flinders Models.  
 
The key outcomes and impacts on the examples described have focused on due uptake 
of the programs by healthcare providers and patients; health service utilisation and 
quality of care outcomes and the results have been mixed. Improvements in patient 
care have not always been associated with reduced health care costs for the 
healthcare system or the patient. As a framework the CCM provides policy makers and 
healthcare professionals with an overview of elements that are considered to be 
essential in the management of people with chronic conditions but it is not clear 
whether the elements are of equal importance in terms of their effect on process of 
care or patient outcomes. 
 
The CCM sets out a framework for understanding the role of the different elements to 
provide health care for people with chronic disease. The descriptions of the adaptations 
of the model in different healthcare settings do not however provide information for 
the evidence of effectiveness for the elements. The next section will use a systematic 
review and review of reviews approach to establish the effectiveness of the elements 
of the CCM when tested experimentally. 
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METHODS FOR THE SYSTEMATIC REVIEW  
The purpose of the systematic review and review of reviews was to identify the 
published experimental evidence to inform the elements of the chronic care model.  In 
particular to answer the following questions: 
1. How effective, efficient and innovative are the models and approaches 
identified? 
2. What are the characteristics of successful (effective, efficient and / or 
innovative) models and approaches in terms of organisation, service delivery 
and funding? How applicable are these to the Australian context and health 
care system? 
3. What are the facilitators and barriers to effective interventions for chronic 
disease in primary health care? 
SEARCH CRITERIA 
Primary research studies meeting the inclusion criteria for the review were identified by 
searching Medline, Embase, CINAHL and PsychLit from January 1990 to February 2006 
and the Cochrane Effective Practice and Organisation of Care (EPOC) specialised 
register (Issue 4, 2005). Terms for the chronic diseases of interest and aspects of 
chronic disease management were combined with terms for primary and community 
care and the EPOC quality filter was applied to include randomised controlled trials 
(RCTs), controlled clinical trials (CCTs), controlled before and after (CBA) and 
interrupted time series (ITS) studies (Appendix 1) for the detailed search strategy.  
Systematic reviews meeting the inclusion criteria were identified by searching the 
Cochrane Library (Issue 4, 2005), the Database of Abstracts of Reviews of Evidence 
(DARE) and the Joanna Briggs Institute (JBI) Library from 1990 to February 2006.  In 
addition to this there was a grey literature search of relevant government and health 
related websites (Appendix 2). The bibliographies of all primary research papers 
included in the review were searched to identify additional studies and systematic 
reviews for inclusion. 
Studies and systematic reviews were included if they were published in the English 
language, published in 1990 or later and the research was undertaken in any of the 
following countries:  Australia, Canada, Netherlands, New Zealand, Scandinavia 
(Sweden, Norway, Denmark, Finland, Iceland), United Kingdom (England, Scotland, 
Wales, Northern Ireland), or USA. 
INCLUSION CRITERIA 
Studies were included in the review if they contained male or female adults aged 18 
years and over with one or more of the following conditions: asthma, heart disease, 
heart failure, hypertension, type 2 diabetes, lipid disorders, chronic obstructive 
pulmonary disease (COPD), arthritis (osteoarthritis or rheumatoid arthritis) and 
osteoporosis. Intervention strategies for patients with chronic diseases were included if 
they addressed organisational, professional or financial interventions as described in 
the EPOC taxonomy of interventions (see Table 1 and Appendix 3 for more detail). The 
EPOC taxonomy was used because the focus of the Cochrane EPOC group is on 
interventions designed to improve professional practice and delivery of health care, 
which fits with the scope of this review. The EPOC taxonomy does not include patient 
mediated interventions and these were expanded for the purpose of this review to 
include: distribution of educational materials, education sessions, motivational 
counselling, brief intervention, community programs, self management and call back 
reminder notice. 
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Studies were included if they objectively measured health professional performance or 
patient outcomes in a clinical setting or self-report measures with known validity and 
reliability. Health professional performance included process outcomes such as 
adherence to disease specific guidelines, disease specific measurements such as blood 
pressure, blood glucose, spirometry, weight, referrals and follow up. Patient outcomes 
included disease control, self report measures with known validity and reliability such 
as well-being, quality of life and disability scores. Patient satisfaction, provider 
satisfaction and economic measures were included. Studies and systematic reviews 
that only evaluated the change in patient knowledge were excluded. 
 
Studies were included in the review if they were randomised or quasi-randomised 
controlled trials (RCTs), controlled clinical trials (CCT), controlled before and after 
studies (CBAs), or interrupted time series (ITS) according to the EPOC criteria (EPOC 
Checklist 2002). If a study did not meet the above criteria it was included in a separate 
category if the research was undertaken in Australia and provided contextual 
information. 
 
Systematic reviews were included in the review where more than 50% of the included 
studies met the above inclusions criteria. Primary research papers that were included in 
the systematic reviews selected for this review were excluded from data extraction so 
that they would not contribute to the results twice. 
QUALITY ASSESSMENT FOR PRIMARY RESEARCH PAPERS 
There were four processes undertaken to select the studies for inclusion in this review. 
Screening 
One reviewer (SD) screened the titles and abstracts of all the articles identified from 
the database and grey literature search strategies. Where there was any doubt as to 
the relevance of the study it remained in the list. Because of the broad nature of the 
research questions it was important that the search strategy was sensitive but not too 
specific. This meant that a large number of articles were identified in the initial search 
that were clearly irrelevant to this review and this initial screen simply removed these 
articles.   
 
Two reviewers (IH and DT) screened the abstracts of the remaining articles 
independently.  Abstracts remained in the list if they did not contain sufficient 
information for a decision to exclude to be made. The results of the screening were 
recorded in Excel spreadsheets for comparison and any disagreements were resolved 
by a third reviewer (SD). 
Verification 
Attempts were made to obtain full-texts of all the articles screened and included in the 
list for verification. The sources utilised included all online sources, library visits, inter-
library loan requests, and purchasing on-line.  Some of the Australian papers were 
collected directly from the author via email or fax. 
 
A study verification form (Appendix 4) was developed (RG and SD) from those used by 
JBI and EPOC.  Two reviewers (IH and DT) independently verified the papers.  Again, 
the results of the verification process were recorded in Excel spreadsheets for 
comparison and any disagreements were resolved by a third reviewer (SD). 
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Quality Assessment 
Quality assessment forms were developed from those used by the JBI and EPOC (RG 
and SD). Separate forms were developed for RCTs and CCTs, CBA and ITS study 
design (Appendices 5,6,7). 
 
Two reviewers (IH and DT) assessed the quality of the articles.  Because of time 
constraints the list of articles was split between the two reviewers with a 19% overlap 
so that an inter-rater reliability test could be performed.  A one-way ANOVA was used 
to calculate mean squares of the scores and then a Spearman-Brown equation was 
used to estimate the inter-rater reliability. The agreement rate was 0.7.   
 
In order to ensure the methodological rigor of included articles it was necessary to 
identify a mechanism to facilitate the identification and subsequent exclusion of studies 
of lesser quality. Sutton et al (56) advocate that the most appropriate method to 
facilitate such identification is to determine a threshold value by either using the mean 
score, median score or calculating the mean score plus one standard deviation.  The 
mean of the scores of 212 studies included in this review that were subjected to quality 
assessment was 10.84 and the median was 11.0. The mean and/or median quality 
scores were adopted as the threshold for defining studies of adequate quality. 
Data extraction 
Data was extracted by two reviewers (DT and IH). A data extraction form (Appendix 8) 
was developed from those used by JBI and EPOC. An MS Access database was 
developed for data entry. Data were entered directly into the Access database while 
articles were being read. 
QUALITY ASSESSMENT FOR SYSTEMATIC REVIEWS 
There were three stages to the process of selecting the systematic reviews for 
inclusion in this review. 
Screening 
One reviewer (SD) screened the titles and abstracts of the systematic reviews 
identified by the database searches and excluded any reviews that did not meet the 
inclusion criteria.  Where there was any doubt as to the review’s relevance the review 
remained in the list. 
Verification 
Attempts were made to obtain full-texts of all the systematic reviews included in the 
list for verification.  The sources utilised included all online sources, and purchasing on-
line.  A verification form for systematic reviews was developed by modifying the study 
verification form with information from published papers (Appendix 9) (57, 58). The 
systematic reviews were verified by one reviewer (SD) and any uncertainties were 
resolved following discussions with the other investigators (NZ, IH, RG). 
Data extraction 
All systematic reviews that met the inclusion criteria after verification underwent data 
extraction. Data were entered into an MS Access database. One reviewer (SD) 
extracted data from the included reviews. 
SNOWBALLING 
One reviewer (DT) screened the bibliographies of all the primary research papers and 
identified primary research articles and systematic reviews for inclusion. All additional 
articles and reviews identified through the snowballing process underwent the 
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screening, verification, quality assessment and data extraction process as detailed 
above. 
CODING THE CHRONIC CARE MODEL 
The interventions described in the primary research papers and the summary tables of 
included studies in the systematic reviews were described using the EPOC taxonomy 
and stored in the MS Access database. The EPOC taxonomy was mapped to the 
elements of the CCM using several published descriptions of the model (6, 8) to assist 
this process and a comparison table was developed (Table 2). This mapping process 
enabled the components of the CCM addressed by each paper to be listed. For the 
analysis it was important that each paper was categorised according to the element of 
the CCM that was considered to be the main focus, eg. self management support. Two 
reviewers (SD and IH) ranked the order of importance of the elements of the chronic 
care model to the review or paper using the results of the mapping from the EPOC 
taxonomy and the specific aims of the review or paper. Any disagreements were 
resolved by a third reviewer (NZ). 
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DATA SYNTHESIS 
The data were synthesised using the approach described by Weingarten et al. (3), 
which was modified for the purposes of this study.  We modified the methods of 
Weingarten et al. because we took a comprehensive approach when including studies 
and recording outcome measures.  This resulted in heterogeneity in the recorded data 
and that prevented us from doing a meta-analysis to explore the effect-sizes. 
 
The outcome measures that we recorded were:   
1. Health care professional adherence to guidelines 
2. Patient outcomes: 
- physiological measures of disease 
- adherence to treatment 
- health service use 
- quality of life 
- risk behaviour 
- satisfaction 
- health status 
- functional status 
 
We entered all the key outcome measures recorded in the studies under each of the 
categories listed above. For each of the categories, if one of the recorded outcome 
measures showed a statistically significant improvement (p value <0.05) that outcome 
measure was coded as a statistically significant improvement.  For example, if a 
randomised controlled trial focussing on diabetes reported HbA1c, blood lipids and 
blood glucose as physiological measures of disease (PMOD) and there was a 
statistically significant improvement (P<0.05) for HbA1c then we recorded the PMOD 
outcome for that study to have produced a positive outcome irrespective of the results 
for blood lipids and glucose.  For the systematic reviews, the published results were 
used in this report. 
 
Tables were produced that summarized the effective outcomes by CCM element.  All 
analyses were performed using SPSS 14.0 for Windows, SPSS Inc. 
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RESULTS 
RESULTS FROM THE PRIMARY RESEARCH PAPERS 
Selection process 
The initial database search identified 5032 relevant articles that were published 
between 1990 and February 2006. An initial screening by a single reviewer reduced 
this to 578. This number was reduced to 399 when screening was undertaken by two 
reviewers through abstract reading. Verification of the full-text resulted in 212 articles 
being selected for quality assessment. The cut-off score for quality was selected at 
11.0. Ninety articles scoring less than 11.0 were discarded. The number of articles 
selected for data extraction was 132 including 10 Australian studies. Data was 
extracted from 126 articles including 10 Australian articles. Data could not be extracted 
from six papers because of inadequate and/or inappropriate reporting. Screening of 
the reference lists of those articles included in the review provided another 19 for data 
extraction. In total data was extracted from 145 articles (Figure 2).  In cases where 
there were multiple papers based on the same study, data was extracted from one 
paper that best matched the purpose of the review. (Included and excluded papers are 
detailed in Appendices 10, 11 and 12). 
 
Fourteen (10 during the initial search and 4 during snow-balling) relevant Australian 
studies identified during the verification stage were included for data extraction and 
were not subjected to quality assessment (Figure 2). 
 
Figure 2.  Selection process of the primary research papers 
Characteristics of the programs  
Of the 145 studies data extracted from the majority (80%) were randomised controlled 
trials (RCT). The next most common study design was controlled before and after 
(CBA) (15.2%). There were two controlled clinical trials (CCT) and one interrupted time 
series (ITS). Four descriptive Australian studies were also included to provide 
additional contextual information. 
 
The majority (64.1%) of the studies were based at primary care settings, 33 in 
community based care and 12 in managed care organisation. Over half of the studies 
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were conducted in the USA followed by 21 in the UK, 15 in the Scandinavia, and 14 in 
Australia.  
 
More than one-third (54) of the studies included in the review had diabetes as the key 
disease-focus. This was followed by hypertension (24), asthma (21), and heart disease 
(19). 
 
 
The number of interventions used in the 145 studies ranged from one to seven with 
nearly one-third of the studies using a single intervention, another third using two, and 
the remaining third using three or more interventions (Table 4). 
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The interventions reported in the studies were categorised using the EPOC taxonomy 
(Appendix 3), which was then mapped to the elements of Chronic Care Model. Patient 
self-management support (SMS) (160) was the most frequently used intervention 
across all the disease groups followed by decision support (DS) (74) for health 
professionals and delivery system design (DSD) (69) (Table 5). The most frequently 
used SMS interventions included patient educational sessions and motivational 
counselling followed by distribution of educational materials among patients. 
Implementation of standard guidelines, educational meetings and distribution of 
educational materials among health professionals were most commonly used DS 
interventions. The most frequently used DSD intervention was multidisciplinary 
teamwork. 
 
There were 30 interventions categorised as clinical information system (CIS) used by 
145 programs. The most frequently used CIS intervention included audit and feedback 
to health professionals. There were only 10 studies that included health care 
organisation (HCO) as an intervention. Of the total of 343 interventions reported in the 
145 studies none of them was categorised as community resource (CR) as per EPOC 
taxonomy. Table 5 shows interventions as per the elements of chronic care model by 
disease. 
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Again, patient self-management support was the most commonly used intervention 
irrespective of the country where the study was conducted as shown in Table 6. There 
was no preponderance of any one type of intervention in any particular country. 
 
 
 
 
 
 
 
 
 
 
Characteristics of the effective interventions 
Results showed that patient SMS was the most effective intervention and it was 
effective across the majority of outcomes measures recorded (Table 7). Within SMS the 
most effective intervention was educational sessions of patients and patient 
motivational counselling (Table 13). Distribution of educational materials among 
patients in association with patient education and motivation produced positive 
outcome for patients’ service use and patient risk behaviour (Table 13).  
DSD in the form of multidisciplinary teamwork produced positive outcome for patients’ 
service use (Tables 7 and 13). 
 
DS and CIS produced positive outcomes for professional adherence to standard disease 
management guidelines. DS interventions that were found to be effective included 
implementation of evidence based guidelines, educational meetings with health 
professionals and distribution of educational materials among health professionals 
(Table 13). Of the CIS interventions audit and feedback was found to be effective in 
assisting health care professionals adhere to guidelines (Table 13).  
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In addition to patient SMS the other elements that produced positive outcome for 
patient physiological measure of disease included DS for health professionals and DSD. 
DS interventions that produced positive outcomes in this regard included 
implementation of evidence-based guidelines, distribution of educational materials 
among health professionals and educational meetings with health professionals (Table 
13). DSD interventions that were effective in controlling disease measures included 
multidisciplinary teamwork. 
 
Key Physiological Measure of Disease 
Table 8 shows the interventions there were effective in controlling three key 
physiological measures of disease. For HbA1c the most effective intervention was DSD 
followed by SMS, whereas, for the other measures the most effective intervention was 
SMS followed by DSD.  
 
Number and type of elements 
Adding multiple elements to the intervention programs did not seem to produce better 
outcomes as shown in Table 9. Again, adding multiple types of elements from the CCM 
did not make the intervention programs more effective (Table 10). 
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Combination of CCM elements 
The combination of DSD and SMS was the most effective combination across the 
majority of the outcome measures (Table 11). The interventions that were most 
effective within this combination were patient educational sessions and 
multidisciplinary teamwork and patient motivational counselling and multidisciplinary 
teamwork. 
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DS in combination with CIS and DSD improved for health care professionals’ adherence 
to guidelines. The most common interventions within these combinations were 
implementation of evidence-based guidelines and audit and feedback and 
multidisciplinary teamwork. 
 
There was a relative lack of evidence of other combinations. 
 
 
Effect by disease  
Self-management support was the most effective intervention across the majority of 
the disease groups. For asthma, SMS improved patients’ quality of life and functional 
status (Table 12). For diabetes, on top of patients’ quality of life, SMS improved 
patients’ physiological measure of disease and patients risk behaviours. SMS had a 
significant impact on service use of patients with heart failure (Table 12). Osteoarthritis 
patients’ functional status was improved because of SMS. The effect of SMS on 
patients with COPD or lipid disorders was minimal. 
 
Delivery system design predominantly had effects on diabetes, hypertension, and lipid 
disorders. It improved physiological disease measures in patients with diabetes, heart 
disease and lipid disorders. In addition, in diabetes and heart disease it also improved 
health services utilisation by patients (Table 12).  
 
Results suggest that DS alone or in association with CIS mainly enhanced the 
management of diabetes (Table 12). DS and/or CIS significantly improved health care 
professionals’ adherence to guidelines. DS also improved physiological control of 
diabetes.  
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Patients suffering from asthma also benefited from DS through better asthma control 
and thus enhanced quality of life.  
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Table 13. Effective interventions as per EPOC Taxonomy 
 
Outcome Measures 
EPOC Taxonomy 
C
C
M
  E
le
m
en
t 
Prof. 
adherenc
e to 
guideline
Patient 
adherence to 
treatment 
Patient 
service 
use 
Patient 
physiological 
measure of 
disease  
Patient 
risk 
behaviour 
Patient 
quality of 
life 
Patient 
health 
status 
Patient 
Satisfac-
tion 
Patient 
functional 
status 
Audit and feedback (prof level) CIS 3   3      
Brief intervention (pat level) SMS          
Call back reminder notice (pat level) CIS  3        
Change to medical records system CIS          
Change to physical structure DSD          
Change to setting of service delivery DSD          
Changes to scope and nature of benefits HCO          
Communication & case discussion (org 
level) DSD        3  
Community programs (pat level) CR          
Consumer partic in governance of org  HCO          
Continuity of care (org level) DSD          
Distribution of educational material 
(pat level) SMS   3  3     
Distribution of educational material 
(prof level) DS 3   3      
Educational meetings (prof level) DS 3   3    3  
Educational outreach visits (prof level) DS 3     3    
Educational sessions (pat level) SMS 3 3 3 3 3 3 3 3 3 
Financial – patient HCO          
Financial – provider HCO          
Formal integration of services (org 
level) HCO          
Implementation of evidence based 
guidelines (prof) DS 3   3  3 3   
Interventions to boost morale (org 
level) DSD          
Local consensus process (prof level) DS          
Local opinion leaders (prof level) DS          
Mail order pharmacy (org level) DSD          
Marketing (prof level) DS          
Mass media (prof level) DS          
Complaints dealing mechanism (org 
level) HCO          
Motivational counselling (pat level) SMS 3  3 3 3   3  
Multidisciplinary teams (org level) DSD 3  3 3   3 3  
Other org intervention HCO          
Other patient interventions           
Other prof intervention (prof level)           
Other structural interventions           
Accreditation & affiliation of 
hospital  HCO          
Patient-mediated interventions (prof 
level) SMS          
Presence of quality monitoring CIS          
Reminders (prof level) CIS          
Revision of professional roles (org 
level) DSD          
Self management (pat level) SMS 3     3    
Skill mix changes (org level) DSD          
Staff organization HCO          
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Economic outcomes 
 
There were eight studies that reported the economic outcomes for their interventions. 
Out of those eight three had DSD as their key intervention and the other five had SMS. 
Of the three DSD studies two reported a statistically significant positive economic 
outcome. For the five SMS studies, none produced positive economic outcomes. 
 
The DSD interventions that were effective in producing positive economic outcomes 
included multidisciplinary teams and continuity of care at the organisational level.  
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EVIDENCE FROM SYSTEMATIC REVIEWS 
A total of 23 systematic reviews met the inclusion criteria and were included in this 
review of reviews. Figure 3 details the stages involved in the identification of the 
reviews and the number excluded at each stage. For a detailed summary of the 
included systematic reviews see Appendix 13. References for the included and 
excluded reviews are listed in Appendices 14 and 15. 
 
 
Figure 3. Selection process of the systematic reviews 
 
The 23 systematic reviews identified addressed four of the elements of the Chronic 
Care Model as their primary focus: 
- Self-management support – eleven reviews, six reviews in diabetes, two in 
asthma, COPD, hypertension and arthritis. 
- Delivery system design – eight reviews, four reviews in diabetes although 2 
reviews are duplicates (59, 60) and the results will be considered together, 
heart disease, hypertension, COPD and asthma. 
- Decision support – two reviews, diabetes and asthma. 
- Clinical information systems – two reviews, diabetes and cardiovascular 
disease and hypertension. 
 
A summary of the results is presented in Table 14. 
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Self-management support (SMS) 
There were eleven systematic reviews that primarily addressed SMS, six reviews in 
diabetes (61-66), two in asthma (67, 68), COPD (69), hypertension (70) and arthritis 
(71). 
 
A total of five reviews reported an increase in patient knowledge with self-management 
support for diabetes (61-63, 65) and COPD (69). Only two of these reviews also 
demonstrated an improvement in patient outcomes associated with the improvement 
in knowledge for diabetes group training (61) and for self-management education in 
community gathering places (63). The results for patient outcomes were unclear for a 
further two reviews of diabetes self-management education (62, 65). HbA1c was 
improved in 14/54 studies but there was also an improvement in both active and 
control groups in a further 15 studies (62). Turnock et al reported an improvement in 
COPD knowledge; whilst this was not associated with an improvement in patient 
outcomes it was associated with better use of antibiotics (69). Patient outcomes were 
improved in a review of behavioural interventions for hypertension; counselling or 
counselling with training was more effective than usual care (70). There was a small 
improvement in pain and disability scores for patients with OA or RA attending arthritis 
self management programs (71). Blood glucose monitoring alone was not associated 
with improvements in patient outcomes (64). 
Characteristics of effective SMS interventions 
Group based self-management support was associated with improved patient 
outcomes for diabetes (61, 63, 65) (Table 15). Loveman et al. reported that group 
based education was particularly effective for interventions that targeted lifestyle 
change and increasing knowledge (65) and that it did not matter which health care 
professional delivered the education as long as they were well trained. Class size was 
not an important factor but annual top up sessions maintained the effect (61). 
Successful interventions were based on therapeutic patient interventions and 
empowerment (62, 63, 70). To be effective interventions had to address motivation to 
change and this seemed to be more effective in a group setting. Patient self 
management was particularly effective in community gathering places such as 
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community groups or church groups because it could be culturally specific and the 
evidence seemed to be applicable to a range of ethnic groups (63). Short term and 
repetitive focused interventions were found to be effective for diet and lifestyle (62, 
65). Simply providing a verbal or written self management plan for asthma was not 
associated with improvements in patient outcomes however regular review improved 
morbidity and lung function, patients in both groups frequently improved (67, 68). 
Barriers to effective SMS interventions 
In general, many authors of the reviews reported that the quality of included studies 
was variable (61-63, 68, 69, 71). A feature of these studies was significant losses to 
follow up so that a selected group of patients remained in the study and patients 
tended to have poor control at baseline (63). Most of the authors reported that many 
of the studies included did not provide sufficient details of the self-management 
interventions used. 
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Table 15. Summary of the results for reviews addressing self-management support 
 
CCM Elements 
† 
Chronic 
disease 
Process outcomes Health service 
utilisation 
Patient outcomes QoL Medication Use Knowledge 
SMS, DS, DSD, 
HCO 
COPD  Hospital admission, 
(n=2) 
WMD 0.16 (95 per cent 
CI –0.09, –0.42) 
Healthcare utilisation, 
(n=1) 
WMD -0.01 (95 per 
cent CI –0.12, – 0.1) 
FEV1  per cent pred (6 months), 
(n=2) 
WMD 1.83 per cent (95 per cent CI -
1.05, 4.71) 
FEV1  per cent pred (12 months), 
(n=1) 
MD 2.00 (95 per cent CI -1.89, 5.89) 
Mortality Peto OR at 12 months  
1.01 (95 per cent CI 0.32, 3.24) 
SGRQ 6 months, (n=2) 
WMD-1.91 ( 95 per cent 
CI -5.46, -1.63) 
SGRQ 12 months, (n=2) 
WMD-0.32 (95 per cent CI 
-3.34, -2.70) 
 
Antibiotics 6 months, 
(n=1) 
MD 6.00 days 95 per 
centCI  1.4 to 10.6 
 
Recognition of stable health, 
(n=1) 
MD 1.10 (95 per cent CI 0.46, 
1.74) 
Recognition of early exac, 
(n=1) 
MD 1.80 (95 per cent CI 0.75, 
2.85) 
Recognition of severe exac, 
(n=1) 
MD 2.50 (95 per cent CI 1.04, 
3.96) 
How to act stable health, (n=1) 
MD 0.5 (95 per cent CI 0.21, 
0.79) 
How to act early exac, (n=1) 
MD 2.3 (95 per cent CI 0.96, 
3.64) 
How to act severe exac, (n=1) 
MD 1.50 (95 per cent CI 0.62, 
2.38) 
SMS, CR, DSD  OA 
RA 
OA+RA 
Other 
  SMS effect on pain, (n=12) 
Effect size 0.12 (95 per cent CI 0.00, 
0.24) 
SMS effect on disability, (n=12) 
0.07 (95 per cent CI 0.00, 0.15) 
   
SMS, CR, DSD Diabetes   HbA1c (12-14 months), (n=7) 
WMD -0.82 ( 95 per cent CI -0.99, -
0.65) 
HbA1c (2 yrs), (n=22) 
WMD -0.97 (95 per cent CI -1.40, -
0.54) 
Weight (12-14 months), (n=5) 
WMD -1.61 (95 per cent CI -2.97, -
0.25) 
Sys (4-6 months) BP, (n=2) 
WMD -5.37 (95 per cent CI -9.53, -
1.21) 
 Reduction diabetes 
medication, (n=5) 
OR 11.79 (95 per cent 
CI5.17, 26.90) 
 
Diabetes knowledge, (n=3) 
Std MD 0.95 (95 per cent CI 
0.72, 1.18) 
SMS, CIS, DSD Asthma  PEF vs symptom SMS, 
hospital admissions, 
(n=4) 
R Risk 1.17 (95 per cent 
CI 0.44, 3.12) 
PEF vs symptom SMS, 
ER visits, (n=5) 
PEF vs Dr review, mean FEV1, 
(n=3) 
SMD 0.10 [-0.05, 0.25 
PEF vs Dr review, mean PEF, (n=3) 
SMD 0.16 (95 per cent CI 0.01, 0.31) 
 PEF vs symptom SMS, 
oral steroids, (n=2) 
R Risk 1.53 (95 per cent 
CI 0.82, 2.87) 
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CCM Elements 
† 
Chronic 
disease 
Process outcomes Health service 
utilisation 
Patient outcomes QoL Medication Use Knowledge 
SMS Asthma  PEF based Written 
plans vs Symptom 
based Written Plans, 
Dr visits, (n=2) 
PEF written plans vs no written 
plan, FEV1, (n=1) 
WMD 2.00 (95 per cent CI -6.41, 
10.41) 
PEF written plans vs no written 
plan, PEF, (n=1) 
WMD 2.10 (95 per cent CI -5.84, 
10.04) 
 PEF based written 
plans vs symptom 
based written plans, 
oral steroid courses, 
(n=2) 
R Risk 2.28 (95 per cent 
CI 1.25, 4.17) 
 
 
SMS Diabetes   HbA1c, (n=6) 
5 no difference 
HbA1c (mean change),  
–0.4 per cent in SMBG and +0.5 per 
cent in control (p<0.05) 
   
SMS Hypertension   Counselling vs Usual care - dias BP, 
(n=2) 
3.2 mmHg improvement in DBP (95 
per cent CI 1.2, 5.3) 
Counselling vs Usual care - sys BP, 
(n=2) 
10 mm Hg improvement in SBP (95 
per cent CI 4.8, 15.6) 
SM vs UC, BP,  
No difference 
C + training, BP,  
4.7mm Hg (95 per cent CI 87, 99) 
   
SMS, CR, DSD Diabetes   Community gathering places, 
HbA1c per cent, (n=4) 
Pooled estimate –1.9 (95 per cent CI –
2.4, –1.4) 
SMS in the home, HbA1c per cent, 
(n=2) 
Pooled estimate –0.5 (95 per cent CI –
1.1, 0.1) 
Community gathering places, 
weight (lbs), (n=6) 
-5.2 (95 per cent CI –9.0, 1.6) 
SMS in the home, weight (lbs), (n=3) 
-2.3 (95 per cent CI –4.5, 0) 
  Community gathering places, 
knowledge, (n=1) 
Improved 
SME in the home, knowledge, 
(n=5) 
Improved 
SMS, DS, CIS, 
DSD 
Diabetes Provider intervention 
on provider outcome, 
(n=4), 
3 improved 
 Patient behaviour intervention, 
effect on patient, (n=4) 
Improved in 4 
Provider behaviour intervention, 
effect on patient, (n=4) 
1 improved 
Provider behaviour 
intervention, 
pyschosocial effect on 
patient, (n=4) 
3 unclear 
Patient behaviour 
intervention, 
pyschosocial effect on 
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CCM Elements 
† 
Chronic 
disease 
Process outcomes Health service 
utilisation 
Patient outcomes QoL Medication Use Knowledge 
patient, (n=4) 
3 improved, 1 unclear 
SMS, DSD, CR Diabetes   HbA1c,  
3/8 studies signif improvement in 
HBA1c 
BP,  
Signif improvement in BP with 
intensive behavioural intervention 
(1/8) 
Weight,  
4/8 report small but significant 
reduction in weight or BMI. Control 
group also lost weight 
HbA1c,  
Signif reduction with diet and 
education (1/8) 
BP,  
NS diff (1/8)Signif reduction in diast 
BP (1/8) 
Weight,  
5/8 NS diff 
QoL, (n=1) 
Signif improvement 
 
 Diabetes knowledge, (n=2) 
Signif improvement 
SMS Diabetes   SMS vs control, HbA1c, (n=54) 
Improved in 14 
SMS vs control, HbA1c, (n=54) 
Both groups improved in 15 
HbA1c (6 months), (n=54) 
Greater improvement at 6 months, 8 
studies 
  Diabetes knowledge, (n=17) 
Signif improvement in 11 
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Delivery system design (DSD) 
There were eight systematic reviews that primarily addressed DSD for diabetes (59, 
60, 72, 73), heart disease (74), hypertension (75), COPD (76) and asthma (77). Two of 
the diabetes reviews were different reports of the same review and the results were 
considered together (59, 60). 
 
Overall there were improvements in process outcomes such as adherence to guidelines 
and increased follow up in four of the reviews targeting patients with heart disease 
(74), diabetes (59, 60, 73) and asthma (77). Patient outcomes were less clear, four 
reviews reported improvements in patient outcomes such as blood pressure (74), 
mortality (59, 60), HbA1c (73) and night waking in asthma (77) (Table 16). Two 
reviews explored the role of nurses as case managers in diabetes (72, 73) and the key 
finding was that case management alone had a limited effect on patient outcomes and 
the effects were not sustained at 12 months (72). Case management for diabetes was 
more effective when combined with intensive disease management (73). 
Characteristics of effective DSD interventions 
When DSD was combined with SMS there were improvements in the patient outcomes 
particularly when case management was combined with disease management (73). 
Much of this evidence came from studies that were conducted in managed care type 
organisations in urban USA and Europe. The key features of many of the DSD 
interventions were the combination of service reorganisation, division of labour with 
professional support and information systems for patient review and recall (73). Follow 
up in primary care was increased compared to secondary care (59, 60)  for diabetes 
and with nurses compared to GPs for heart disease (74). 
 
Most of the reviews highlighted the improvements in process of care outcomes such as 
smoking cessation (74), improved follow up (59, 60), improvements in diabetes checks 
such as foot and eye checks (59, 73) that were associated with DSD interventions but 
this was not always accompanied by improvements in patient outcomes. 
Barriers to effective DSD interventions 
The barriers to effective DSD interventions tended to occur at the organisational level. 
In order to be effective there had to be a change from a reactive system of health care 
to a system that was proactive (73). The roles of the members of multi-disciplinary 
team needed to be clearly defined and where there was no reimbursement for 
delivering patient reminders for follow up the process was less effective (73). 
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Decision support (DS) 
There were two systematic reviews that primarily addressed DS in the management of 
diabetes and asthma (Table 17). Renders et al (78) explored the effectiveness of 
professional and organisational interventions on the management of diabetes and 
Barton et al explored the impact of education for doctors on the management of 
asthma (79). Both reviews concluded that health professional education alone did not 
improve patient outcomes but may have some effect on provider outcomes such as 
adherence to guidelines in diabetes. 
 
One of the reviews included under CIS also addressed the impact of health 
professional education on the management of hypertension (80). Again, health 
professional education alone did not improve blood pressure control compared to 
health professional education in combination with intensive protocol driven care. 
Characteristics of effective DS interventions 
Renders et al explored the combinations of interventions likely to be effective in the 
management of diabetes (78). When health professional interventions were combined 
with delivery systems design including patient reminders and recall there was an 
improvement in patient outcomes although this occurred more often where baseline 
care was poor and many of the studies were undertaken in USA. 
 
Adding register recall to the interventions reduced the number of people lost to follow 
up. Combinations of health professional education with revision of professional roles or 
patient education were also more likely to improve patient outcomes. 
Barriers to effective interventions 
There were none identified for these reviews. 
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Clinical information systems (CIS) 
There were two systematic reviews that primarily addressed CIS (80, 81) (Table 18)  
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Garg et al. (81) reported on the effectiveness of computerised decision support 
systems for the management of diabetes and cardiovascular disease. Fahey et al (80) 
explored the effectiveness of clinical guidelines with a system of reminders to increase 
follow up on the control of hypertension. 
 
Both reviews reported that CIS was associated with an improvement in process 
outcomes such adherence to disease specific guidelines for hypertension (80), diabetes 
and cardiovascular disease (81). Computerized clinical decision systems in isolation 
were not associated with improvements in patient outcomes such as HbA1c (81) but 
when combined with health professional led care or intensive protocol driven care 
there were significant improvements in blood pressure control in hypertensive patients 
(80). Appointment reminders increased the likelihood of patients attending for follow 
up (Table 18).  
Characteristics of effective CIS interventions 
Both reviews combined the CCM elements of CIS and DS. There were several 
characteristics of clinical information system interventions that seemed to increase the 
effectiveness on provider or patient outcomes. Many computer systems used disease 
specific guidelines to prompt care, the guidelines based prompts that automatically 
prompted care were found to be more effective than prompts that the health 
professional had to manually activate (81). Systems where the target end-user health 
professionals were also involved in the development tended to be preferred. 
 
The features of successful hypertension management were that the care was free, 
register recall of patients and vigorous “stepped care” when the patients attended for 
review. The patient reminders were essential to increase patient attendance for follow 
up. The authors suggested that health care should be organised in such a way with 
systems that remind patients to attend for regular review. If these systems were in 
place then health professionals could deliver intensive guideline driven care when the 
patients attended for review (80). Both elements were believed to be essential and two 
year follow up of the patients once the intensive stepped care aspect of the study had 
ceased showed that there was a decline in blood pressure control (82). 
Barriers to effective CIS interventions 
The effectiveness of any computerised decision support system depended on the 
quality of the guideline prompts and patient data included. Garg et al noted that many 
of the studies included in their review had employed research staff to enter data or 
deliver prompted care (81) which has implications when applying the results to the 
clinical setting where entered data may be inadequate and dedicated data entry staff 
are not available. 
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Health care organisation 
There were no published systematic reviews that primarily addressed the role of health 
care organisation in chronic disease management. 
Community resources 
There were no published systematic reviews that primarily addressed the role of 
community resources in chronic disease management. 
 
KEY FINDINGS 
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DISCUSSION AND CONCLUSIONS 
The Chronic Care Model (CCM) provides a useful conceptual framework for 
understanding the elements considered essential for the management of chronic 
disease and the interplay between the elements. However, not all of the elements of 
the CCM can be assessed experimentally for their effectiveness or efficiency and this 
was illustrated by the lack of research evidence to support the role of Health Care 
Organisation and Community Resources in this review. 
 
The evidence to support the elements of the CCM in primary care presented in this 
review was focused at the meso and micro levels of care. At the level of the element 
there was evidence that interventions that addressed delivery system design improved 
adherence to guidelines, patient service use and physiological measures of disease. 
Self-management support was effective at the patient level outcomes such as 
physiological measures of disease, quality of life, health status and satisfaction. Clinical 
information systems and decision support were effective at improving adherence to 
guidelines with some evidence for patient outcomes for decision support. These results 
support a previous analysis of the elements of the CCM by Tsai et al (8) and further 
analysis of patient and provider interventions by Weingarten et al (3). Much of the 
evidence presented in this review referred to the management of adults with type 2 
diabetes and may not be applicable to all chronic diseases. 
 
It would have been useful to have identified some HCO and CR approaches that had 
been shown to be effective in supporting the effective meso and micro level 
interventions. The only evidence for these elements has been obtained from examples 
of health system change in comparable countries that may be useful to the Australian 
context and was from program evaluation as opposed to experimental evidence. The 
focus of this review was to explore the use of the model in primary health care context 
and its application to the Australian healthcare system. 
 
The number of elements of the CCM addressed by the intervention was not associated 
with improved patient or process outcomes and this supported previous reports of the 
CCM (8). 
SELF-MANAGEMENT SUPPORT 
The aim of self-management support is to develop skills and confidence within patients 
and their families so that they can take responsibility for their own care (4, 5). The 
self-management support strategies that were found to be most effective were those 
that developed self-efficacy in relation to specific behaviours such as diet and diabetes 
rather than those that were more general. Self efficacy theory underpins this process 
and this can only be interpreted and measured in regard to specific behaviours, such 
as diabetes self management or diet and exercise behaviours and not broadly in 
relation to a range of behaviours such as chronic disease self management in general 
(83, 84). Self-management support in group settings was more effective than that 
offered on a one to one basis and was specific to behaviours. Self-management 
support in community gathering places was also found to be effective and useful for 
targeting specific ethnic groups. Simply providing written information such as asthma 
action plans was not associated with improvements in lung function for asthma and 
there was less effect in those conditions such as arthritis and COPD where the disease 
progression was more difficult to modify although there were often improvements in 
health status, quality of life or disease knowledge. 
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Interventions that addressed self-management support reported improvements in 
patient use of services and intermediate health outcomes such as physiological 
measures of disease, health and functional status, quality of life, health service use and 
knowledge for diabetes. There was also improvement in physiological measures of 
disease for hypertension and small improvements for arthritis. The evidence was less 
clear for asthma and COPD.  
Much of the evidence presented in this review focused on self-management support for 
diabetes. Patient education, self management and empowerment of people with 
diabetes and their carers, has been a focus for diabetes management for many years. 
Diabetes is a complex disorder and the majority of sufferers will develop complications 
that result in significant morbidity and high rates of mortality. Achieving optimal control 
of blood glucose levels has been demonstrated to delay the onset of the complications 
and engaging patients in their care has been demonstrated to promote adherence to 
treatment and hence improve quality of life. 
 
The Flinders Model of chronic care management is one model that has been developed 
in Australia and is a clinician led model, which emphasises the education of the primary 
health care team and has been tested in some states (39). The Flinders Model is a 
generic model of chronic disease self management based on cognitive behavioural 
therapy and involves goal setting, care planning and review.  
 
Other models such as the Stamford Model (46, 47) and Expert Patient Program (EPP) 
(20) are also effective. The review found that using motivational approaches and 
targeting specific behaviours were the characteristics of effective interventions rather 
than the self management model used. Health care professionals, especially practice 
nurses, can play an important role in facilitating chronic disease self management. 
However, to do this they need adequate training to effectively support the 
development and maintenance of self-efficacy and skills in chronic disease self 
management. This is even more challenging because self-efficacy is specific to a 
particular behaviour and not general. Thus a set of skills required to manage the SNAP 
risk factors for example, may not be applicable for monitoring glucose or adherence to 
medication plans. Self-efficacy and behavioural skills can be supported in group 
sessions with peers, and by vicarious experience. 
 
Current lifestyle education for GPs and practice staff has been based on stages of 
change theory rather than self-management support, which is based on self-efficacy 
theory. While this has been demonstrated to be useful for supporting behaviour 
change in relation to smoking and alcohol, it is less well suited to other aspects of self 
management, which require development of skills. There is a need to incorporate self-
management education into existing programs such as lifestyle scripts as well as into 
annual cycles of care for chronic disease. 
 
The National Chronic Disease Strategy (55) highlights some of the difficulties that 
currently exist with the integration of self-management support into the Australian 
health care setting. Several recommendations have been made that SMS should be 
encouraged and supported at all entry points to the health care system. In Australia, 
self management strategies and programs have been developed with relatively little 
engagement of general practitioners and have not been established as integral 
components of the primary health care system. Training of primary health care 
providers should be provided to encourage use of self-management support strategies 
in routine practice. The new Australian Better Health Initiative will address some of the 
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self management training needs in primary care at both a Commonwealth and State or 
Territory level. In addition to a range of self-management support activities such as 
face-to-face and group training. 
 
While the literature did not identify any experimental evidence assessing the impact of 
self-management support in Indigenous communities, an evaluation report from the 
Eyre Peninsula suggests that chronic disease self management can be effectively 
delivered to Aboriginal populations by Aboriginal health workers (85). There have been 
secondary prevention examples in Aboriginal communities that have involved the whole 
community in making dietary changes. The key features of these programmes have 
been the role of the community in the intervention (86-88). 
 
Self management policy options 
- Engage primary care through the development of more programs to support 
the training of GPs and practice nurses in chronic disease self management in 
general practice. 
- Develop programs to support community health, multicultural and Aboriginal 
health workers in chronic disease self management. 
- Encourage or mandate the inclusion of self-management education into care 
plans and structured care for chronic disease such as the annual cycle of care 
for diabetes. 
- Link the referral to allied health providers under the current Medicare 
arrangements to self-management support in general practice. For example, 
the referral of a patient with diabetes to a dietician for dietary advice supported 
by self-management education by the practice nurse. 
- Explore the role of Divisions of General Practice in providing self-management 
support for their general practices. 
- Support self management by linking general practice with community health, 
multicultural health and Aboriginal health services to provide group self-
management support targeted for specific ethnic groups. 
- Explore how the home medicines review could be utilised to enable pharmacists 
to support self management. 
DELIVERY SYSTEM DESIGN 
Delivery system design was effective in improving patient use of services, patient 
outcomes and health professional adherence to guidelines particularly for heart 
disease, diabetes and asthma. In combination with self-management support it was 
effective in improving physiological measures of disease, health and functional status 
and quality of life particularly for hypertension and diabetes. Nurses acting as case 
managers were effective in diabetes when combined with self-management support. 
Innovations in delivery system design were often designed to promote self-
management support. 
 
The delivery system design interventions found to be effective included the 
development of multidisciplinary team care especially the role of practice nurses, use of 
patient reminders and proactive follow up which are central to the switch from acute to 
chronic care. There were also examples of primary care teams sharing care for patients 
with specialist teams in diabetes. Many of these features were key components of the 
system wide changes in USA and in the Evercare trials in the UK. 
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Unlike the UK with the PCTs and the USA with Managed Care Organisations, Australian 
primary health care is still characterised by a preponderance of small or solo practices 
which are only loosely linked into primary care organisations such as Divisions. 
However, this is changing, between 1990 and 2003 the proportion of practices in 
Australia with 4 or more GPs increased from 34.3 per cent (29.7–39.0) to 59.8 per cent 
(56.7–62.9) (89). The role of the practice nurse in Australia is less well developed than 
in countries such as the UK, Netherlands or Scandinavia where practice nurses are 
highly trained, particularly in the management of chronic diseases such as asthma and 
diabetes. Many of the initiatives to improve chronic disease management in the UK 
such as the Evercare trials have been dependent on practice nurses for their 
implementation and success. Expanding the role of the practice nurse to include 
responsibility for the management of people with chronic disorders is a logical 
progression of the GPs role as case manager and coordinator of care, however there 
could be significant workforce issues in Australia if practice nurses are going to take on 
more responsibility for the management of people with chronic disease. A survey by 
the RACGP found that of the 222 practice nurses surveyed, over 75 per cent were 
involved in care plans and chronic disease management but very few of these nurses 
had received formal training (90).  
 
The Better Outcomes in Mental Health (BOiMH) initiative is an Australian example of a 
health care delivery model that has proved effective in terms of uptake and positive 
results for patients. The initiative combines decision support (training of GPs), delivery 
system design (the 3-step process - assessment, care plan and review and access to 
psychologist and/or psychiatrist) and patient self-management support (education for 
patients by psychologist). All of these elements are supported by a financial support 
system. The results have been positive and there has been good uptake of the 
initiative but it has been difficult for Divisions of General Practice to manage the 
demand within the recommended budget (44).  
 
The National Chronic Disease Strategy (NCDS) lists several recommendations that 
target delivery system design in primary care under the proposals for integration and 
continuity of care. These include risk stratification and case management where 
routine care planning and self management are insufficient. There is a need to develop 
the funding structures to support multidisciplinary care and care planning more 
effectively to overcome the fragmented nature of the Australian healthcare system. 
There is also a need for greater coordination between the services especially to 
improve the referral pathways between services. Delivery system design is of particular 
importance in Aboriginal health to overcome the problems of healthcare delivery in 
remote areas and barriers to access even in urban areas. 
Delivery system design policy options 
- Extend the financial support for practice nurses to become more involved in self 
management, especially group programs for patients in general practice, 
including self-management education. This involves the removal of the 
geographical restrictions of access to PIP incentives for practice nurses. It also 
involves establishing new MBS item numbers for chronic disease management 
by practice nurse. 
- Extend the financial support for practice nurses to provide group clinics and 
outreach visits for patients with chronic disease, including self-management 
support. 
- Support training of primary care staff in a multidisciplinary team approach to 
management of chronic disease. Training should focus on clear roles and 
responsibilities of the team members. 
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- Link the referral to allied health providers under the current Medicare 
arrangements to self-management support in general practice. For example, 
referral to dietician linked to self-management education by practice nurse. 
 
DECISION SUPPORT AND CLINICAL INFORMATION SYSTEMS 
Decision support and clinical information systems will be considered together as there 
was considerable overlap in the interventions used. Overall both decision support and 
clinical information systems improved health professional adherence to guidelines for a 
range of chronic disease in primary care, particularly diabetes. Many of the 
interventions involved the use of disease specific guidelines and the incorporation of 
these guidelines into computer systems to provide prompts and feedback on 
performance. Health professional education alone did not improve patient outcomes. 
 
Disease specific guidelines are already in use in Australia, encouraged by financial 
systems such as the SIP and PIP payments to general practitioners on completion of 
condition related tasks. However, uptake of these incentives has not been universal 
amongst practitioners, partly because the system is complex (42) and further 
complicated by the fact that they are disease specific rather than providing an holistic 
approach which may make it difficult to manage patients with several chronic diseases. 
 
General practices in Australia use a variety of computer software and the quality of the 
information entered varies. In order to manage chronic disease effectively and act on 
performance feedback, there is a need for complete and accurate patient data. This 
may be difficult for small practices or solo practitioners who may not have the support 
to update this information. 
Decision support policy options  
- Further develop practice incentive payment (PIP) and service incentive payment 
(SIP) programs to encourage guideline-based chronic disease management. 
- Integrate chronic disease SIP and PIP incentives so that patients are not 
considered as a series of separate chronic diseases. 
- Encourage greater use of streamlined SIP and PIP incentives to improve quality 
of care. 
- Encourage the use of chronic disease registers; only diabetes is supported by 
PIP at present. Encourage the use of registers in the provision of audit data for 
practices to use in quality improvement process. 
- Support the use of data extraction tools and Collaboratives methodology 
including Plan/Do/Study/Act (PDSA) cycles to improve the quality and use of 
practice data. 
- Continue to support the development and revision of disease specific 
guidelines. 
- Develop programs to support the training of GPs and practice nurses in 
guideline-based chronic disease management in general practice. 
- Provide support to GPs and practice staff so that they can make more effective 
use of clinical information systems for patients with chronic illness. 
 
HEALTH CARE ORGANISATION AND COMMUNITY RESOURCES 
There was no experimental evidence for the effect of health care organisation or 
community resources on the management of chronic disease. Interventions that 
address these elements such as incentives and support for widespread change are 
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often facilitators or barriers to the success of interventions such as self-management 
support or delivery system design. Health care organisation and community resources 
are also specific to the healthcare system that the CCM is operating in but it would be 
useful to have some evidence for effective health care organisation or community 
mechanisms to support effective meso or micro level interventions. 
 
At the macro level there needs to be a reorganisation of the burden of chronic disease. 
The descriptions from comparable countries provided some examples of the responses 
of different healthcare systems to the challenge of chronic disease. However, it is not 
clear from these examples the extent of the role of the organisational level changes in 
the success of the programs and how this might be transferable to other healthcare 
systems. 
 
ADVANTAGES AND DISADVANTAGES OF THIS REVIEW PROCESS 
The aim of this review was to use a systematic approach to identifying the best 
available evidence for chronic disease management from counties comparable to 
Australia. By using methodology developed by the Cochrane Collaboration, JBI and 
Centre for Reviews and Dissemination (CRD) the search has been extensive, 
transparent and comprehensive. Previous reviews of chronic disease management 
have included primary and secondary care and the advantage of this review was that it 
focused on issues specific to primary care and primary health care professionals. The 
combination of the results from published systematic reviews and primary research 
papers added to the strength of this review and the results extend those of Tsai (8) 
and Weingarten (3). 
 
The topic of the review generated a significant number of potential studies however 
those studies that did not demonstrate high levels of scientific rigour were excluded 
based on a mean score of 11 on the quality assessment scale. There was little 
homogeneity among the outcomes and interventions therefore a formal statistical 
analysis such as meta analysis was not possible and a narrative analysis was 
undertaken. The short time frame also precluded the team undertaking an additional 
review to determine the cost effectives of the elements of the model. 
 
ABORIGINAL AND TORRES STRAIT ISLAND COMMUNITIES 
The prevalence of chronic disease in the Aboriginal and Torres Strait is high particularly 
for diabetes, heart disease, hypertension and renal disease. The age standardised 
prevalence for diabetes in Aboriginal and Torres Strait Islanders is 11 per cent 
compared to 3 per cent for non-indigenous Australians and in 2002 36 per cent of 
indigenous adults aged fifteen years and over had a disability or long term condition 
(51). 
 
The search strategy for the review identified only one randomised controlled trial of an 
intervention to improve diabetes care in a remote Indigenous community (91). The 
intervention was primarily delivery system design; a diabetes recall system and training 
of the local healthcare workforce in diabetes management. The intervention resulted in 
greater adherence to diabetes guidelines by health professionals and a reduction in 
health service use such as hospital admission for diabetes complications. The 
remaining papers identified were reports of projects or programs in Aboriginal 
communities, which did not meet the inclusion criteria for the main part of the review. 
 
AUSTRALIAN PRIMARY HEALTH CARE RESEARCH INSTITUTE 
 
 
61 
________________________________________________________________________________ 
  
Within in the context of the Audit and Best practice for Chronic Disease (ABCD) 
project, which was undertaken in the Northern Territory, there was an assessment of 
health systems using the Assessment of Chronic Illness Care (ACIC) which is a tool 
based on the Chronic Care Model (53). Overall the scores indicated that for the 
participating health centres most of the elements of the CCM were present in the 
health centres but at a basic level. A regression analysis was used to determine the 
level of association between ACIC score and quality of diabetes care and patient 
outcomes. The elements that they identified to be the most important were HCO and 
CIS with CR important for process of care and DSD for patient outcomes. There was 
limited uptake and evidence for self-management support in these health centres. 
 
The results from the ABCD project reflect the types of interventions and programs that 
have been tested in Aboriginal and Torres Strait Island populations. Many of the 
problems faced by these populations relate to access to health care services. A quarter 
of the Australian Aboriginal and Torres Strait Island population live in remote areas and 
between 16.7 per cent to 54.1 per cent of the communities live more than 10 km from 
the local health centre and in the Northern Territory only 37 per cent have access to a 
working telephone (51). Many of the projects in remote areas have targeted delivery 
system design and how sustainable health services and programs can be delivered. For 
the 30 per cent of Aboriginal and Torres Strait Islanders that live in major cities there 
are still problems with access to health services. Urban dwelling Aboriginal people did 
not feel confident with mainstream GPs who may not be sensitive to or aware of 
Aboriginal health issues (92) or where the GP does not know the Aboriginal Health 
Worker (93).. In addition to this they experience considerable social disadvantage with 
poor access to transport and local services. 
 
The results of main review identified DSD and SMS as having an impact on patient and 
process outcomes, especially in diabetes. The elements of DS and CIS improved health 
professional adherence to guidelines. There was no experimental evidence for the role 
of HCO and CR which seem to be important to the success of interventions or 
programs to improve chronic disease management in Aboriginal populations (94). 
Audits and evaluations of programs have tended to target delivery system design in 
terms of the development of disease registers, multidisciplinary team care, recall 
system and care planning (95-98) (91). The Co-ordinated Care trials in Aboriginal 
populations demonstrated that the pooling of funding supported improvements to 
healthcare access and investment in infrastructure, care planning and the role of 
community empowerment (99). Many of the programs have demonstrated 
improvements in patient and process outcomes but have been difficult to sustain in the 
long term (95). Features of successful interventions in terms of those that improve 
patient or process outcomes require community involvement and commitment. 
 
There have been few interventions that have targeted self management in these 
populations. The Indigenous demonstration projects of the Sharing Health Care 
Initiative  suggested that there had been improvements in the health of the 
participants and that community engagement was a key feature of the Indigenous 
demonstration projects and that a “bottom-up” approach to self management with 
community led initiatives was likely to be the sustainable model. The Eyre Peninsula 
chronic disease self management project demonstrated that self-management support 
by Aboriginal health Workers was successful in improving patient outcomes and 
highlighted the complex and often dysfunctional social situation of those involved (85). 
Self-management support in the CCM involves the patient and their family but in some 
of the indigenous communities this family support may not be available. With 
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involvement of the whole community there have been improvements in patient 
outcomes associated with secondary prevention interventions such as dietary 
interventions in remote communities (86-88). 
 
Much of the indigenous literature has been focused on interventions in remote 
communities and more research is required to support urban populations who also 
experience considerable morbidity and mortality. If the delivery system design issues 
can be addressed then the evidence presented in this review would support self-
management support for chronic disease and possible approaches would include group 
sessions and in community gathering places. In order for this to happen there would 
need to be training and support for the Aboriginal Health workers in self management. 
Indigenous health policy options 
- Support SMS education and support for Aboriginal Health workers 
- Support SMS and community involvement 
 
Capacity and sustainability are the key issues for the success of programs in 
Indigenous communities. 
 
SUMMARY 
The Chronic Care Model provides a useful conceptual framework for understanding 
some of the elements considered essential for the management of chronic disease and 
the interplay between the elements. The elements that most frequently impacted on 
physiological measures of disease, health and function status, and quality of life were 
self-management support and delivery system design particularly when in combination. 
Decision support and clinical information systems played an important role in health 
professional adherence to guidelines. There was little evidence for changes in health 
care organisation and community resources because they are difficult to assess 
experimentally. 
 
A number of issues with using the Chronic Care Model to guide evidence based care of 
chronic disease have been identified in the course of this review. The first of these is 
the lack of literature for the impact of interventions focussed on two elements of the 
model – Health Care Organisation and Community Resources. These elements are 
relatively difficult to assess experimentally but in the real world may be of considerable 
importance to the overall success of chronic disease management programs.  
 
The next issue is the lack of research evidence for the impact of the chronic care 
model as a whole. This is understandable as it is usually not feasible to test entire 
health system changes, which require substantial organisational reform, in an 
experimental design. This inevitably leaves doubt as to the effectiveness of applying 
the Chronic Care Model although the work that has been done in comprehensive health 
systems change for example in the Veterans Administration in the US has been noted 
and provides some insight.  
 
The final issue is that the Chronic Care Model, while a very helpful conceptual 
framework, may not provide sufficient practical guidance at the level of the health 
service to assist policy and decision makers to plan and guide organisation and delivery 
of services. This implies a need for the development of capacity in health services to 
translate the Chronic Care Model into fully developed proposals and programs for 
health service reform. 
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